Global Dry Powder Inhaler Device Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

According to APO Research, The global Dry Powder Inhaler Device market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dry Powder Inhaler Device is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Dry Powder Inhaler Device is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Dry Powder Inhaler Device is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Dry Powder Inhaler Device is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Dry Powder Inhaler Device include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind and Mylan, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dry Powder Inhaler Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Dry Powder Inhaler Device, also provides the sales of main regions and countries. Of the upcoming market potential for Dry Powder Inhaler Device, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dry Powder Inhaler Device sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Dry Powder Inhaler Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Dry Powder Inhaler Device sales, projected growth trends, production technology, application and end-user industry.


Dry Powder Inhaler Device Segment by Company

GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura

Dry Powder Inhaler Device Segment by Type

Single Dose
Multi Dose

Dry Powder Inhaler Device Segment by Application

Asthma
COPD
Others

Dry Powder Inhaler Device Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Powder Inhaler Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Powder Inhaler Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Powder Inhaler Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dry Powder Inhaler Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dry Powder Inhaler Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dry Powder Inhaler Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Dry Powder Inhaler Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Dry Powder Inhaler Device Market Size, 2020 VS 2024 VS 2031
1.3 Global Dry Powder Inhaler Device Market Size Estimates and Forecasts (2020-2031)
1.4 Global Dry Powder Inhaler Device Sales Estimates and Forecasts (2020-2031)
1.5 Global Dry Powder Inhaler Device Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Dry Powder Inhaler Device Market Dynamics
2.1 Dry Powder Inhaler Device Industry Trends
2.2 Dry Powder Inhaler Device Industry Drivers
2.3 Dry Powder Inhaler Device Industry Opportunities and Challenges
2.4 Dry Powder Inhaler Device Industry Restraints
3 Dry Powder Inhaler Device Market by Manufacturers
3.1 Global Dry Powder Inhaler Device Revenue by Manufacturers (2020-2025)
3.2 Global Dry Powder Inhaler Device Sales by Manufacturers (2020-2025)
3.3 Global Dry Powder Inhaler Device Average Sales Price by Manufacturers (2020-2025)
3.4 Global Dry Powder Inhaler Device Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Dry Powder Inhaler Device Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Dry Powder Inhaler Device Manufacturers, Product Type & Application
3.7 Global Dry Powder Inhaler Device Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Dry Powder Inhaler Device Market CR5 and HHI
3.8.2 Global Top 5 and 10 Dry Powder Inhaler Device Players Market Share by Revenue in 2024
3.8.3 2024 Dry Powder Inhaler Device Tier 1, Tier 2, and Tier 3
4 Dry Powder Inhaler Device Market by Type
4.1 Dry Powder Inhaler Device Type Introduction
4.1.1 Single Dose
4.1.2 Multi Dose
4.2 Global Dry Powder Inhaler Device Sales by Type
4.2.1 Global Dry Powder Inhaler Device Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Dry Powder Inhaler Device Sales by Type (2020-2031)
4.2.3 Global Dry Powder Inhaler Device Sales Market Share by Type (2020-2031)
4.3 Global Dry Powder Inhaler Device Revenue by Type
4.3.1 Global Dry Powder Inhaler Device Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Dry Powder Inhaler Device Revenue by Type (2020-2031)
4.3.3 Global Dry Powder Inhaler Device Revenue Market Share by Type (2020-2031)
5 Dry Powder Inhaler Device Market by Application
5.1 Dry Powder Inhaler Device Application Introduction
5.1.1 Asthma
5.1.2 COPD
5.1.3 Others
5.2 Global Dry Powder Inhaler Device Sales by Application
5.2.1 Global Dry Powder Inhaler Device Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Dry Powder Inhaler Device Sales by Application (2020-2031)
5.2.3 Global Dry Powder Inhaler Device Sales Market Share by Application (2020-2031)
5.3 Global Dry Powder Inhaler Device Revenue by Application
5.3.1 Global Dry Powder Inhaler Device Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Dry Powder Inhaler Device Revenue by Application (2020-2031)
5.3.3 Global Dry Powder Inhaler Device Revenue Market Share by Application (2020-2031)
6 Global Dry Powder Inhaler Device Sales by Region
6.1 Global Dry Powder Inhaler Device Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Dry Powder Inhaler Device Sales by Region (2020-2031)
6.2.1 Global Dry Powder Inhaler Device Sales by Region (2020-2025)
6.2.2 Global Dry Powder Inhaler Device Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Dry Powder Inhaler Device Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Dry Powder Inhaler Device Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Dry Powder Inhaler Device Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Dry Powder Inhaler Device Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Dry Powder Inhaler Device Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Dry Powder Inhaler Device Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Dry Powder Inhaler Device Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Dry Powder Inhaler Device Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Dry Powder Inhaler Device Revenue by Region
7.1 Global Dry Powder Inhaler Device Revenue by Region
7.1.1 Global Dry Powder Inhaler Device Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Dry Powder Inhaler Device Revenue by Region (2020-2025)
7.1.3 Global Dry Powder Inhaler Device Revenue by Region (2026-2031)
7.1.4 Global Dry Powder Inhaler Device Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Dry Powder Inhaler Device Revenue (2020-2031)
7.2.2 North America Dry Powder Inhaler Device Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Dry Powder Inhaler Device Revenue (2020-2031)
7.3.2 Europe Dry Powder Inhaler Device Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Dry Powder Inhaler Device Revenue (2020-2031)
7.4.2 Asia-Pacific Dry Powder Inhaler Device Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Dry Powder Inhaler Device Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Dry Powder Inhaler Device Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 GlaxoSmithKline
8.1.1 GlaxoSmithKline Comapny Information
8.1.2 GlaxoSmithKline Business Overview
8.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
8.1.5 GlaxoSmithKline Recent Developments
8.2 AstraZeneca
8.2.1 AstraZeneca Comapny Information
8.2.2 AstraZeneca Business Overview
8.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 AstraZeneca Dry Powder Inhaler Device Product Portfolio
8.2.5 AstraZeneca Recent Developments
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Comapny Information
8.3.2 Boehringer Ingelheim Business Overview
8.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
8.3.5 Boehringer Ingelheim Recent Developments
8.4 Chiesi
8.4.1 Chiesi Comapny Information
8.4.2 Chiesi Business Overview
8.4.3 Chiesi Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Chiesi Dry Powder Inhaler Device Product Portfolio
8.4.5 Chiesi Recent Developments
8.5 Cipla
8.5.1 Cipla Comapny Information
8.5.2 Cipla Business Overview
8.5.3 Cipla Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Cipla Dry Powder Inhaler Device Product Portfolio
8.5.5 Cipla Recent Developments
8.6 3M
8.6.1 3M Comapny Information
8.6.2 3M Business Overview
8.6.3 3M Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 3M Dry Powder Inhaler Device Product Portfolio
8.6.5 3M Recent Developments
8.7 Hovione
8.7.1 Hovione Comapny Information
8.7.2 Hovione Business Overview
8.7.3 Hovione Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Hovione Dry Powder Inhaler Device Product Portfolio
8.7.5 Hovione Recent Developments
8.8 Mannkind
8.8.1 Mannkind Comapny Information
8.8.2 Mannkind Business Overview
8.8.3 Mannkind Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Mannkind Dry Powder Inhaler Device Product Portfolio
8.8.5 Mannkind Recent Developments
8.9 Mylan
8.9.1 Mylan Comapny Information
8.9.2 Mylan Business Overview
8.9.3 Mylan Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Mylan Dry Powder Inhaler Device Product Portfolio
8.9.5 Mylan Recent Developments
8.10 Novartis
8.10.1 Novartis Comapny Information
8.10.2 Novartis Business Overview
8.10.3 Novartis Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Novartis Dry Powder Inhaler Device Product Portfolio
8.10.5 Novartis Recent Developments
8.11 Schering/Merck
8.11.1 Schering/Merck Comapny Information
8.11.2 Schering/Merck Business Overview
8.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Schering/Merck Dry Powder Inhaler Device Product Portfolio
8.11.5 Schering/Merck Recent Developments
8.12 Teva
8.12.1 Teva Comapny Information
8.12.2 Teva Business Overview
8.12.3 Teva Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Teva Dry Powder Inhaler Device Product Portfolio
8.12.5 Teva Recent Developments
8.13 Vectura
8.13.1 Vectura Comapny Information
8.13.2 Vectura Business Overview
8.13.3 Vectura Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Vectura Dry Powder Inhaler Device Product Portfolio
8.13.5 Vectura Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Dry Powder Inhaler Device Value Chain Analysis
9.1.1 Dry Powder Inhaler Device Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Dry Powder Inhaler Device Production Mode & Process
9.2 Dry Powder Inhaler Device Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Dry Powder Inhaler Device Distributors
9.2.3 Dry Powder Inhaler Device Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings